Pages that link to "Q43893918"

The following pages link to Anxiolytic-like effects of AP7 injected into the dorsolateral or ventrolateral columns of the periaqueductal gray of rats (Q43893918):

Displaying 25 items.

• Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders (Q24623179) (← links)
• Viral vector induction of CREB expression in the periaqueductal gray induces a predator stress-like pattern of changes in pCREB expression, neuroplasticity, and anxiety in rodents (Q30490211) (← links)
• Xenon in the treatment of panic disorder: an open label study (Q33795860) (← links)
• Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats (Q34774970) (← links)
• The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines (Q35071483) (← links)
• The neurobiology and control of anxious states (Q35202929) (← links)
• An Experimental Study to Evaluate the Effect of Memantine in Animal Models of Anxiety in Swiss Albino Mice (Q36077324) (← links)
• Microinjection of muscimol into the periaqueductal gray suppresses cardiovascular and neuroendocrine response to air jet stress in conscious rats (Q36877643) (← links)
• Fine-tuning of defensive behaviors in the dorsal periaqueductal gray by atypical neurotransmitters (Q37990798) (← links)
• Antiaversive effects of cannabinoids: is the periaqueductal gray involved? (Q41351855) (← links)
• Inhibition of the NMDA receptor/Nitric Oxide pathway in the dorsolateral periaqueductal gray causes anxiolytic-like effects in rats submitted to the Vogel conflict test. (Q42154035) (← links)
• Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice (Q42680585) (← links)
• Ketamine induces rapid onset of antidepressant action: neurophysiological biomarkers as predictors of effect (Q43061598) (← links)
• Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats (Q43270515) (← links)
• Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats (Q43415378) (← links)
• Ionotropic glutamate-receptor antagonists inhibit the aversive effects of nitric oxide donor injected into the dorsolateral periaqueductal gray of rats (Q44573217) (← links)
• Glutamatergic neurotransmission as molecular target in anxiety (Q44773109) (← links)
• Role of glutamate NMDA receptors and nitric oxide located within the periaqueductal gray on defensive behaviors in mice confronted by predator. (Q46110245) (← links)
• NMDA receptor activation antagonizes the NMDA antagonist-induced antianxiety effect in the elevated plus-maze test in mice. (Q46243465) (← links)
• Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats. (Q46619355) (← links)
• Anxiety-like responses induced by nitric oxide within the BNST in mice: Role of CRF1 and NMDA receptors (Q47595920) (← links)
• The dorsolateral periaqueductal grey N-methyl-D-aspartate/nitric oxide/cyclic guanosine monophosphate pathway modulates the expression of contextual fear conditioning in rats (Q47982416) (← links)
• Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses (Q48369538) (← links)
• Long lasting effects of predator stress on pCREB expression in brain regions involved in fearful and anxious behavior (Q50638909) (← links)
• Chapter 4.4 The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders (Q57513867) (← links)